Sun BioPharma Provides Business Update and Reports Operating Results for FY2019
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic cancer, provided a business update and reports financial results for the year ended December 31, 2019. Sun BioPharma is developing SBP-101, a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance […]
Algernon Appoints Novotech As CRO for Phase 2 Coronavirus Ifenprodil Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, announced that it has chosen to appoint award winning Novotech as the contract research organization (CRO) for a planned physician initiated study of NP-120 (Ifenprodil) for COVID-19 infected patients in South Korea. Novotech is an internationally recognized full service CRO known for its experience across […]
Reflections on a 10-Year Journey in the Microbiome
Following a fortuitous path, researcher Aaron Cowley established expertise in process development for live biotherapeutic products at his company Captozyme. Today, as part of CDMO Arranta Bio, he is looking forward to helping drug developers bring the first microbiome-based therapies to the market. Dr. Aaron B. Cowley is the chief scientific officer at Arranta Bio, […]
Digital Mental Health Solution Offers Group Teletherapy to Universities
UF startup and UF Innovate | The Hub graduate company TAO Connect, a digital platform designed to make behavioral health therapy more accessible and effective, announced the addition of its Group Room feature, while also offering its video conferencing services to all 180 of its university partners. With this update, TAO Connect is giving more […]
Dr. Fredy Altpeter to Be Presented the 2020 Distinguished Scientist Award
Dr. Fredy Altpeter, professor of agronomy at UF/IFAS, will be awarded the 2020 Distinguished Scientist Award at the World Congress on In Vitro Biology. The Society of In Vitro Biology established the Distinguished Scientist Award in 2014 to recognize outstanding mid-career scientists who have made significant contributions to the field of in vitro biology and/or […]
Clinical Trial of Radiation Therapy Offers Complete Treatment in Fewer Visits
Diagnosed with invasive ductal carcinoma, one of the most common types and earliest stages of breast cancer, Michele, a grandmother and full-time caregiver to her husband, is today cancer-free thanks to the radiation therapy she received at the Siteman Cancer Center. The clinical trial was based on the use of the breakthrough ViewRay MRIdian technology, […]
Coronavirus and Parkinson’s Disease
Watch Dr. Michael S. Okun, chair and professor in the Department of Neurology at the University of Florida, administrative director and co-director of the Center for Movement Disorders and Neurorestoration within the McKnight Brain Institute, and national medical director for the Parkinson’s Foundation, along with UF infectious disease expert, Dr. Frederick S. Southwick, talk about […]
Molekule Research: The Research and Innovation Behind The Filter Technology
UF startup Molekule Director of R&D Jaspreet Dhau and Co-Founder and Co-CEO Dilip Goswami explains how research, science, and innovation play a role in furthering the PECO (Photo Electrochemical Oxidation) technology, and how that extends to improving the lives of their customers.
Certain Compounds May Block Coronavirus From Cells, UF Health Researcher Finds
Computer simulations run by a University of Florida Health researcher have shown that three compounds appear to have the potential to block cells from being infected by the novel coronavirus COVID-19. The next step involves validation of the findings by David A. Ostrov, Ph.D., an associate professor in the UF College of Medicine’s department of […]
AGTC Announces Completion of Enrollment in All Adult Dose Groups of Its Ongoing Phase 1/2 Clinical Trials in Patients With Achromatopsia
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including […]